Enfusion, Clearwater

Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for $1.5 billion.
Clearwater acquires Enfusion in $1.5B financial software deal
Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock.
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry.
Clearwater Analytics to acquire Enfusion in $1.5 billion deal
Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday. Enfusion shareholders will receive $5.85 in cash and $5.
Clearwater Analytics to Acquire Enfusion, Will Expand Investment Management Platform
Clearwater Analytics (NYSE: CWAN) and Enfusion, Inc. (NYSE: ENFN) announced their entry into a definitive merger agreement.
Clearwater to buy Enfusion for $1.5bn
Clearwater Analytics is building out its investment management platform through the $1.5 billion acquisition of SaaS outfit Enfusion.
Clearwater to acquire Enfusion to expand its Investment Management Platform
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride in covering 400+ technology vendors globally – the largest by any analyst firm in this space.
Clearwater To Acquire Enfusion - Quick Facts
Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion
Clearwater Analytics to buy Enfusion for $11.25 a share
Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately equal mix of cash and stock. Clearwater (NYSE:CWAN) is expected to pay a total of approximately $760M in cash and issue between approximately 23M and 28M new shares to Enfusion (NYSE:ENFN) shareholders.
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker ...
bovnews1d
What’s Fueling Clearwater Analytics Holdings Inc (CWAN) Stock’s 12.21% Gain Above Its 200-Day SMA?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 22.42% ...
Clearwater Analytics upgraded to Buy at DA Davidson on ‘strategic’ Enfusion deal
DA Davidson upgraded Clearwater Analytics (CWAN) to Buy from Neutral with a price target of $32, down from $35. The company’s proposed merger ...
GAMMA Investing LLC Buys 468 Shares of Clearwater Analytics Holdings, Inc. (NYSE:CWAN)
GAMMA Investing LLC raised its stake in shares of Clearwater Analytics Holdings, Inc. (NYSE:CWAN – Free Report) by 57.4% ...